1,913 Shares in Danaher Co. (DHR) Purchased by Financial Consulate Inc.

Financial Consulate Inc. bought a new stake in Danaher Co. (NYSE:DHR) during the third quarter, HoldingsChannel.com reports. The fund bought 1,913 shares of the conglomerate’s stock, valued at approximately $208,000.

Other institutional investors and hedge funds have also added to or reduced their stakes in the company. Mitchell Capital Management Co. grew its holdings in Danaher by 31.6% in the 2nd quarter. Mitchell Capital Management Co. now owns 7,962 shares of the conglomerate’s stock valued at $786,000 after buying an additional 1,914 shares during the last quarter. Private Wealth Partners LLC grew its holdings in Danaher by 14.3% in the 2nd quarter. Private Wealth Partners LLC now owns 95,800 shares of the conglomerate’s stock valued at $9,454,000 after buying an additional 11,961 shares during the last quarter. Centaurus Financial Inc. grew its holdings in Danaher by 20.3% in the 2nd quarter. Centaurus Financial Inc. now owns 3,026 shares of the conglomerate’s stock valued at $299,000 after buying an additional 510 shares during the last quarter. CIBC Asset Management Inc grew its holdings in Danaher by 12.5% in the 2nd quarter. CIBC Asset Management Inc now owns 68,204 shares of the conglomerate’s stock valued at $6,730,000 after buying an additional 7,565 shares during the last quarter. Finally, OppenheimerFunds Inc. grew its holdings in Danaher by 1.5% in the 2nd quarter. OppenheimerFunds Inc. now owns 350,122 shares of the conglomerate’s stock valued at $34,550,000 after buying an additional 5,048 shares during the last quarter. 76.80% of the stock is currently owned by hedge funds and other institutional investors.

Shares of DHR stock traded down $0.29 during mid-day trading on Monday, reaching $96.85. The stock had a trading volume of 3,188,831 shares, compared to its average volume of 2,966,243. The company has a current ratio of 1.53, a quick ratio of 1.08 and a debt-to-equity ratio of 0.38. Danaher Co. has a one year low of $91.41 and a one year high of $110.13. The company has a market capitalization of $68.09 billion, a P/E ratio of 24.03, a P/E/G ratio of 1.87 and a beta of 1.01.



Danaher (NYSE:DHR) last announced its quarterly earnings data on Thursday, October 18th. The conglomerate reported $1.10 EPS for the quarter, topping the Zacks’ consensus estimate of $1.07 by $0.03. Danaher had a return on equity of 11.59% and a net margin of 14.07%. The company had revenue of $4.85 billion during the quarter, compared to the consensus estimate of $4.80 billion. During the same quarter last year, the company earned $1.00 EPS. The company’s quarterly revenue was up 7.2% on a year-over-year basis. Sell-side analysts predict that Danaher Co. will post 4.51 earnings per share for the current fiscal year.

The business also recently announced a quarterly dividend, which was paid on Friday, October 26th. Investors of record on Friday, September 28th were given a dividend of $0.16 per share. The ex-dividend date was Thursday, September 27th. This represents a $0.64 annualized dividend and a dividend yield of 0.66%. Danaher’s dividend payout ratio (DPR) is presently 15.88%.

A number of analysts have commented on the company. Zacks Investment Research downgraded Danaher from a “hold” rating to a “sell” rating in a research report on Monday, July 16th. Royal Bank of Canada raised their price objective on Danaher to $107.00 and gave the stock a “positive” rating in a research report on Thursday, July 19th. They noted that the move was a valuation call. ValuEngine upgraded Danaher from a “hold” rating to a “buy” rating in a research report on Thursday, July 12th. Morgan Stanley raised their price objective on Danaher from $120.00 to $122.00 and gave the stock an “overweight” rating in a research report on Friday, July 20th. Finally, Bank of America set a $113.00 price objective on Danaher and gave the stock a “buy” rating in a research report on Thursday, July 19th. One analyst has rated the stock with a hold rating and fifteen have given a buy rating to the company’s stock. The company currently has a consensus rating of “Buy” and a consensus price target of $112.14.

In related news, Chairman Mitchell P. Rales bought 1,080 shares of the business’s stock in a transaction that occurred on Tuesday, July 31st. The stock was acquired at an average price of $102.32 per share, for a total transaction of $110,505.60. Following the transaction, the chairman now directly owns 1,827,953 shares of the company’s stock, valued at $187,036,150.96. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Thomas Patrick Joyce, Jr. sold 104,913 shares of the firm’s stock in a transaction that occurred on Tuesday, July 31st. The stock was sold at an average price of $101.88, for a total value of $10,688,536.44. Following the transaction, the insider now owns 276,438 shares of the company’s stock, valued at approximately $28,163,503.44. The disclosure for this sale can be found here. Insiders have sold a total of 248,361 shares of company stock valued at $24,995,159 in the last 90 days. 11.90% of the stock is owned by corporate insiders.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company's Life Sciences segment provides laser scanning, compound, surgical, and other stereo microscopes. This segment also offers filtration, separation, and purification technologies to the biopharmaceutical, food and beverage, medical, aerospace, microelectronics, and general industrial sectors.

Featured Article: Price to Earnings Ratio (PE)

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Co. (NYSE:DHR).

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply